• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION FLEXIMA APDL; TUBE, DRAINAGE, SUPRAPUBIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION FLEXIMA APDL; TUBE, DRAINAGE, SUPRAPUBIC Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Inflammation (1932)
Event Date 08/12/2018
Event Type  Injury  
Manufacturer Narrative
Date of event: publication date used.Initial reporter facility name: (b)(6).Devrim akinci, emre unal, turkmen turan ciftci, sara kyendyebai, osman abbasoglu, okan akhan.Endobiliary radiofrequency ablation in the percutaneous management of refractory benign bilioenteric anastomosis strictures.Ajr 2019; 212:w83 through w91.
 
Event Description
It was reported via a journal article that cholangitis occurred.Twenty-one patients (11 men) with a mean age of 47.9 years (range, 26 to 73 years) underwent percutaneous balloon dilatation and long-term drainage for benign bilioenteric anastomosis strictures.Endobiliary rfa was performed in six patients (four men; mean age, 53.1 years; range, 43 to 63 years) whose strictures did not respond to balloon dilatation and long-term drainage.The presenting symptoms of the 21 patients were jaundice (n = 21), right upper quadrant pain (n = 19), pruritus (n = 17), and cholangitis (n = 1 5).T he patients had undergone cholecystectomy (n = 11; 52.4%), choledochal cyst excision (n = 3; 14.3%), right hepatic lobectomy (n = 3; 14.3%), whipple surgery (n = 3; 14.3%), and kasai procedure (n = 1; 4.8%), which resulted in hepaticojejunostomy (n = 17; 81.0%), choledochojejunostomy (n =3; 14.3%), and choledochoduodenostomy (n = 1; 4.8%).The mean interval between the surgery and development of symptoms was 1384 days (range, 4 to 7592 days).In the follow-up period, seven patients (33%) with catheters developed cholangitis symptoms due to catheter-related complications, and they were managed with catheter exchange and antibiotic therapy.There were no major complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLEXIMA APDL
Type of Device
TUBE, DRAINAGE, SUPRAPUBIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC
2546 first street
propark, el coyol
CS  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key14879817
MDR Text Key295116332
Report Number2134265-2022-07482
Device Sequence Number1
Product Code FFA
Combination Product (y/n)N
Reporter Country CodeTU
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 06/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/30/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-